Zhejiang Yatai Pharmaceutical Co., Ltd. (SHE:002370)
China flag China · Delayed Price · Currency is CNY
6.62
0.00 (0.00%)
Apr 29, 2026, 3:04 PM CST

SHE:002370 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
586.46618.72743.85720.47757.62821.11
Cash & Short-Term Investments
616.52618.72743.85720.47757.62821.11
Cash Growth
-20.63%-16.82%3.25%-4.90%-7.73%-9.06%
Accounts Receivable
125.52155.05111.68111.8115.6585.24
Other Receivables
0.610.5326.429.1915.141.18
Receivables
126.13155.58138.08140.99130.7986.42
Inventory
100.94107.2570.1389.4795.260.9
Other Current Assets
14.4716.723.14.2421.2327.41
Total Current Assets
858.06898.27955.16955.181,005995.85
Property, Plant & Equipment
290.36294.73338.11364.79385.89433.99
Long-Term Investments
36.3138.0138.4937.7540.9658.27
Other Intangible Assets
42.714454.259.2157.2251.57
Long-Term Deferred Tax Assets
----0.25-
Long-Term Deferred Charges
5.454.715.8211.3722.1471.1
Other Long-Term Assets
---1.0812.56-
Total Assets
1,2331,2801,4021,4291,5241,611
Accounts Payable
76.84103.9745.7751.889.8353.93
Accrued Expenses
6.1913.1317.0816.9822.7321.65
Short-Term Debt
--30.0650.0650.06-
Current Portion of Long-Term Debt
--301.7--110.16
Current Portion of Leases
----1.71.35
Current Income Taxes Payable
1.635.15----
Current Unearned Revenue
14.1614.752.237.9614.472.77
Other Current Liabilities
9.7115.2419.635.0143.5824.3
Total Current Liabilities
108.53152.24416.44161.8222.38214.15
Long-Term Debt
---639.48900.01861.58
Long-Term Leases
-----1.34
Long-Term Unearned Revenue
2.933.214.365.566.8315.16
Long-Term Deferred Tax Liabilities
3.733.983.863.613.555.94
Other Long-Term Liabilities
--4.9338.0489.8379.65
Total Liabilities
115.18159.43429.59848.51,2231,178
Common Stock
745.67745.67728.59609.17536.69536.62
Additional Paid-In Capital
2,0052,0051,9071,5941,3101,309
Retained Earnings
-1,633-1,630-1,727-1,761-1,749-1,616
Comprehensive Income & Other
--63.35138.8203.57203.8
Total Common Equity
1,1181,120972.18580.87301.27432.96
Shareholders' Equity
1,1181,120972.18580.87301.27432.96
Total Liabilities & Equity
1,2331,2801,4021,4291,5241,611
Total Debt
--331.75689.54951.78974.43
Net Cash (Debt)
616.52618.72412.130.94-194.16-153.31
Net Cash Growth
29.44%50.14%1232.00%---
Net Cash Per Share
0.830.840.600.05-0.37-0.29
Filing Date Shares Outstanding
739.29742.56728.59609.17536.69536.62
Total Common Shares Outstanding
739.29742.56728.59609.17536.69536.62
Working Capital
749.53746.04538.72793.38782.46781.7
Book Value Per Share
1.511.511.250.720.180.81
Tangible Book Value
1,0751,076917.99521.67244.04381.39
Tangible Book Value Per Share
1.451.451.170.630.070.71
Buildings
--429.39427.32413.92426.8
Machinery
--224.35221.97220.86221.01
Construction In Progress
--0.030.03-0.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.